JACQUALYN A FOUSE Insider Trading $AGIO AGIOS PHARMACEUTICALS, INC.
FREE EMAIL WATCHDOG
Get free email notifications about insider trading for JACQUALYN A FOUSE.
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insider Transactions | Monthly Overview
Get the latest insider transactions of JACQUALYN A FOUSE. JACQUALYN A FOUSE is see remarks in CELGENE CORP /DE/ ($CELG) and Director in INCYTE CORP ($INCY) and Director in DICKS SPORTING GOODS INC ($DKS) and Chief Executive Officer in AGIOS PHARMACEUTICALS INC ($AGIO) and Director in AGIOS PHARMACEUTICALS INC ($AGIO) and Director in PERRIGO Co plc ($PRGO).
JACQUALYN A FOUSE in AGIOS PHARMACEUTICALS, INC.
Industry: PHARMACEUTICAL PREPARATIONS [2834]
Position of JACQUALYN A FOUSE: Chief Executive Officer, Director
Holdings: 61,761 shares
Current Value: $2,743,424
Latest Transaction: Feb 17 2021
$AGIO Market Capitalization: $1.88B
$AGIO Previous Close: $44.42
Last 4 weeks trend: HOLD
Last 3 months trend: HOLD
Latest Insider Trading Transactions of JACQUALYN A FOUSE in AGIOS PHARMACEUTICALS, INC.
| 1 Week | 2 Weeks | 1 Month | 3 Months | 6 Months | 1 Year | 2 Years | |
|---|---|---|---|---|---|---|---|
| No. of Purchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Purchases ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| No. of Sales | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Value of Sales ($) | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
Sentiment: All, AGIO, CELG, DKS, INCY, PRGO
Page: 1
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Option Exercise | M | 0.00 | 11,333 | 0 | 22,667 | |
| Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Payment of Exercise | F | 0.00 | 3,398 | 0 | 58,363 | 61.8 K to 58.4 K (-5.50 %) |
| Feb 17 2021 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Buy | M | 0.00 | 11,333 | 0 | 61,761 | 50.4 K to 61.8 K (+22.47 %) |
| Apr 15 2020 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Option Exercise | M | 0.00 | 12,379 | 0 | 24,759 | |
| Apr 15 2020 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Payment of Exercise | F | 40.64 | 3,673 | 149,271 | 50,428 | 54.1 K to 50.4 K (-6.79 %) |
| Apr 15 2020 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Buy | M | 0.00 | 12,379 | 0 | 54,101 | 41.7 K to 54.1 K (+29.67 %) |
| Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Option Exercise | A | 0.00 | 34,000 | 0 | 34,000 | |
| Feb 19 2020 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Option Exercise | A | 51.51 | 137,000 | 7,056,870 | 137,000 | |
| Nov 15 2019 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Buy | P | 31.00 | 40,322 | 1,249,982 | 41,722 | 1.4 K to 41.7 K (+2,880.14 %) |
| May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Option Exercise | M | 0.00 | 1,400 | 0 | 0 | |
| May 31 2019 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Buy | M | 0.00 | 1,400 | 0 | 1,400 | 0 to 1.4 K |
| Feb 05 2019 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Option Exercise | A | 0.00 | 42,695 | 0 | 42,695 | |
| Feb 05 2019 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Chief Executive Off ... | Option Exercise | A | 53.87 | 350,346 | 18,873,139 | 350,346 | |
| Dec 05 2017 | AGIO | AGIOS PHARMACEUTIC ... | FOUSE JACQUALYN A | Director | Option Exercise | A | 61.17 | 16,000 | 978,720 | 16,000 |
Page: 1